Showing 191-200 of 7439 results for "".
High-Dose Ipilimumab Shows Benefits in Advanced Melanoma: Implications for Care
https://practicaldermatology.com/topics/skin-cancer-photoprotection/high-dose-ipilimumab-shows-benefits-in-advanced-melanoma-implications-for-care/20687/Although treatment is associated with a high rate of toxicity, survival benefit is extended at a higher dose.A Non-Invasive 2-Gene Molecular Assay Shows Promise in Assessment of Pigmented Lesions
https://practicaldermatology.com/topics/skin-cancer-photoprotection/a-non-invasive-2-gene-molecular-assay-shows-promise-in-assessment-of-pigmented-lesions/20705/More studies are needed, but a non-invasive assay that identified melanoma gene expression could support clinical decision making.Skin Cancer Prevention, Mohs Data, Allergan Closes on Zeltiq
https://practicaldermatology.com/topics/practice-management/dermwiretv-skin-cancer-prevention-mohs-data-allergan-closes-on-zeltiq/18479/It's Skin Cancer Awareness Month. Joel L. Cohen, MD and Shadi Kourosh, MD share tips on patient education and skin protection. Plus, new data set the stage for developing best practices for Mohs micrographic surgery. Wendy Lewis offers tips for digital marketing success. Plus, Allergan closes the deThe Male Aesthetic Patient: Who He Is and What He Needs
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/the-male-aesthetic-patient-who-he-is-and-what-he-needs/18701/Baby boomer men aren't necessarily driving the growth in male aesthetics. Terrence Keaney, MD says that millennial men in their 30s and 40s are most likely to seek treatments. In the initial consultation, education is essential so men understand the treatments offered and recognize that you understaCures All
https://practicaldermatology.com/topics/practice-management/cures-all/20771/What will the 21st Century Cures Act mean for dermatologists?All About Acne in 2017
https://practicaldermatology.com/topics/psoriasis/all-about-acne-in-2017/20777/Dermatologist Linda Stein Gold, MD discusses new directions in acne treatment.Advances in Treating NMSC
https://practicaldermatology.com/topics/skin-cancer-photoprotection/advances-in-treating-nmsc/18742/Dr. Goldenberg discusses the benefits of timed sequential therapy using two modalities — destructive therapy followed by field therapy — for actinic keratoses. He also talks about treatment options for advanced basal cell carcinoma, squamous cell carcinoma, and merkel cell carcinoma.Laser Advice for Early Adopters
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/laser-advice-for-early-adopters/18809/“Fat melting is not a passing phase,” says Amy Forman Taub, MD. The technology is in its infancy, but applications will expand, she says. Dr. Taub, a laser and device expert offers suggestions on evaluating and choosing devices for a cosmetic practice. GenerationsCellfina Cleared, Finacea Foam Approved
https://practicaldermatology.com/topics/skin-cancer-photoprotection/dermwiretv-cellfina-cleared-finacea-foam-approved/18866/The FDA has cleared Cellfina (Ulthera Inc./Merz Aesthetics, Inc.) to treat cellulite, with results lasting for up to 2 years. Finacea Foam (azelaic acid, Bayer Dermatology) is approved for Rosacea, and Almirall invests in Suneva Medical, maker of Bellafill. Also in this edition, a look at the data oNon-invasive “Mega” Laser Combinations: How to Achieve Maximal Results
https://practicaldermatology.com/topics/practice-management/non-invasive-mega-laser-combinations-how-to-achieve-maximal-results/21150/Improved outcomes and shortened downtime are just some of the advantages of multi-modality approaches to the evolving non-invasive aesthetic front.